Bayesian modeling improves SNP detection in breast cancer, suggesting new avenues for genetic research.
Complex human diseases, including cancer, are linked to genetic factors. Genome-wide association studies (GWASs) are powerful for identifying genetic variants associated with cancer but are limited by their reliance on case–control data. We propose approaches to expanding GWAS by using tumor and paired normal tissues to investigate somatic mutations. We apply penalized maximum likelihood estimation for single-marker analysis and develop a Bayesian hierarchical model to integrate multiple markers, identifying SNP sets grouped by genes or pathways, improving detection of moderate-effect SNPs. Applied to breast cancer data from The Cancer Genome Atlas (TCGA), both single- and multiple-marker analyses identify associated genes, with multiple-marker analysis providing more consistent results with external resources. The Bayesian model significantly increases the chance of new discoveries.
No takes yet. Share an insight, caveat, or question.
Bu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: